Related Experiment Videos
Atopic dermatitis and the indoor climate. The effect from preventive measures.
H I Beck1, P Bjerring, H Harving
1Department of Dermatology and Venereology, Marselisborg Hospital Arhus, Denmark.
Acta Dermato-Venereologica
|January 1, 1989
Summary
Moving to a new home improved atopic dermatitis (AD) symptoms in patients. While indoor climate factors like air exchange and temperature improved, specific allergens like dust mites remained unchanged, suggesting AD is multifactorial.
Area of Science:
- Environmental Medicine
- Dermatology
- Allergology
Background:
- Atopic dermatitis (AD) is a chronic inflammatory skin condition.
- The role of indoor environmental factors in AD exacerbation is increasingly recognized.
- Optimizing indoor climate may influence AD symptom severity.
Purpose of the Study:
- To evaluate the clinical impact of improved indoor climate on atopic dermatitis (AD) patients.
- To correlate changes in specific indoor environmental factors with AD symptom improvement.
- To investigate the multifactorial nature of AD in relation to indoor air quality.
Main Methods:
- Clinical and subjective assessments of AD severity in nine patients before and after relocation.
- Monitoring of indoor environmental parameters including air exchange, humidity, temperature, dust mites, and organic solvents over two years.
- Comparison with a control group of ten AD patients who did not move.
Main Results:
- Patients who moved to homes with improved air exchange, humidity, and temperature showed significant clinical improvement in AD.
- Levels of house dust mites, respirable particles, and organic solvents did not change significantly.
- No single indoor environmental factor was directly correlated with the observed clinical improvement.
Conclusions:
- Improved indoor climate parameters, specifically air exchange rate, relative humidity, and room temperature, positively impacted AD symptoms.
- The study supports the concept that atopic dermatitis (AD) is a multifactorial disease.
- Indoor climate appears to be a significant contributing factor influencing eczema severity in AD patients.